Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Testing effectiveness (Phase 2)Study completedNCT02336815
What this trial is testing

Selinexor Treatment of Refractory Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 202
Not applicableLooking for participantsNCT07035691
What this trial is testing

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

Who this might be right for
Colorectal CarcinomaPolypColorectal Adenoma
Queen Mary University of London 582
Testing effectiveness (Phase 2)Active Not RecruitingNCT06171685
What this trial is testing

MMRC Horizon One: RRMM (MMRC-099)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Multiple Myeloma Research Consortium 300
Testing effectiveness (Phase 2)Study completedNCT01559935
What this trial is testing

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 74
Early research (Phase 1)Looking for participantsNCT07541391
What this trial is testing

Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 12
Testing effectiveness (Phase 2)Study completedNCT03497325
What this trial is testing

Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing

Who this might be right for
Cesarean Section Complications
Ain Shams University 134
Early research (Phase 1)UnknownNCT04474340
What this trial is testing

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Who this might be right for
Moderate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral
Ministry of Health, Kuwait 300
Not applicableStudy completedNCT00742989
What this trial is testing

Effect of Osteopathic Lymphatic Treatment on Plasma Volume, Protein Concentration and Albumin Concentration.

Who this might be right for
Healthy Volunteers
Kansas City University of Medicine and Biosciences 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05552976
What this trial is testing

Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb 606
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Not applicableStudy completedNCT01966991
What this trial is testing

Prenatal Screening for Down Syndrome With DNAFirst

Who this might be right for
Trisomy 21Trisomy 18Trisomy 13+1 more
Women and Infants Hospital of Rhode Island 100
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Not applicableNot Yet RecruitingNCT06638008
What this trial is testing

Ultrasound Guided Placental Growth Factor Vs Platelet Rich Plasma Injection in Peripheral Nerve Injury: an Interventional Study

Who this might be right for
Peripheral Nerve Injury Upper Limb
Assiut University 75
Early research (Phase 1)Study completedNCT02286817
What this trial is testing

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Attention-deficit Hyperactivity Disorder (ADHD)
Aevi Genomic Medicine, LLC, a Cerecor company 30
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Not applicableLooking for participantsNCT07706413
What this trial is testing

Plasma Exchange in Children With Severe Sepsis and Septic Shock

Who this might be right for
Severe Sepsis
Menoufia University 22
Not applicableLooking for participantsNCT07501897
What this trial is testing

Investigating the Impact of Cold Atmospheric Plasma Treatment on Wound Healing at Cannulation Sites in Patients Following Extracorporeal Life Support

Who this might be right for
ExtraCorporeal Life Support (ECLS)Wound InfectionSurgical Site Infection+2 more
National Taiwan University Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT06536413
What this trial is testing

ATRA and Carfilzomib in Plasma Cell Myeloma Patients

Who this might be right for
Multiple Myeloma
The Methodist Hospital Research Institute 42
Next Page